2009
DOI: 10.1007/s00125-009-1632-0
|View full text |Cite
|
Sign up to set email alerts
|

Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas

Abstract: Aims/hypothesis Recent studies have demonstrated that in adult murine beta cells the forkhead box O1 (FOXO1) transcription factor regulates proliferation and stress resistance. However, the role of FOXO1 during pancreatic development remains largely unknown. The present study aimed to characterise the expression of the FOXO1 transcription factor in the early to mid-gestation human fetal pancreas and to understand its role in islet cell development. Methods Human (8-21 week fetal age) pancreases were examined u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
38
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(46 citation statements)
references
References 40 publications
4
38
0
Order By: Relevance
“…In the pancreas FoxO1 negatively regulates expression of Pdx1, which regulates ␤-cell development and mass by competing with the transcription factor FoxA2 for binding to the Pdx1 promoter (24). This is one of the main effects that mediates the suppressive effect of pancreatic FoxO1 on ␤-cell differentiation (25). A similar functional and physical interaction of FoxO1 with Notch1 is described in myoblasts, which leads to corepressor clearance from the Notch effector Csl, leading to stabilization of a functional FoxO1-Notch1 complex (12).…”
Section: Discussionmentioning
confidence: 99%
“…In the pancreas FoxO1 negatively regulates expression of Pdx1, which regulates ␤-cell development and mass by competing with the transcription factor FoxA2 for binding to the Pdx1 promoter (24). This is one of the main effects that mediates the suppressive effect of pancreatic FoxO1 on ␤-cell differentiation (25). A similar functional and physical interaction of FoxO1 with Notch1 is described in myoblasts, which leads to corepressor clearance from the Notch effector Csl, leading to stabilization of a functional FoxO1-Notch1 complex (12).…”
Section: Discussionmentioning
confidence: 99%
“…Loss and gain of FOXO1 function has been investigated in the tissues and cells of various genetically modified mice, including hepatocytes (18,19,25,82), brain (95), muscle (20,45,55), adipose (17,88), pancreas (2,3,84), and heart (99) ( Table 1). …”
Section: Foxo1 In Regulation Of Metabolismmentioning
confidence: 99%
“…The development and proliferation of b-cells require multiple transcription factors-pancreatic and duodenal homeobox 1 (PDX1), neurogenin 3, and cytokeratin 19-that induce expression of insulin, islet amyloid polypeptide, and Glut2, but suppresses glucagon expression (1,3). In the human fetal pancreas FOXO1 has been found to negatively regulate b-cell differentiation by suppressing PDX1, neurogenin 3, and NKX61 (3).…”
Section: Targeting Foxo1 In Metabolic Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…FoxO1 is a member of the family of winged-helix/forkhead transcription factors that serve important roles in cellular differentiation, proliferation, apoptosis, and the response to cellular stress in many tissues. FoxO1 is highly expressed in ␤-cells and is a key regulator of ␤-cell development, mass, and function (13)(14)(15)(16). The best described FoxO1 target gene in ␤-cells is Pdx1 (17).…”
Section: Peroxisome Proliferator-activated Receptor ␥ (Ppar␥)mentioning
confidence: 99%